CILOA

ciloa-logo

Ciloa technology is the only one allowing to produce all types of membrane proteins with their native conformation on exosomes. It allows to load exosomes with cytosolic proteins as well. It thus makes it possible to reach the most difficult families of membrane protein targets, known as “undruggable”, some being the most promising for therapies.Ciloa takes advantage of the natural properties of exosomes; they are natural immuno-stimulators, biocompatible, intercellular membrane messengers, and able to cross all the human body barriers including the blood-brain barrier.

#SimilarOrganizations #People #Website #More

CILOA

Social Links:

Industry:
Legal Medical Therapeutics

Address:
Montpellier, Languedoc-Roussillon, France

Country:
France

Website Url:
http://www.ciloa.fr

Status:
Active

Contact:
+33 (0) 467 143 997

Email Addresses:
[email protected]

Total Funding:
5 M EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Google Universal Analytics Font Awesome Apache


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

Current Employees Featured

mealy-kong_image

Mealy KONG
Mealy KONG CFO @ Ciloa
CFO

robert-mamoun_image

Robert MAMOUN
Robert MAMOUN CEO @ Ciloa
CEO

Official Site Inspections

http://www.ciloa.fr Semrush global rank: 5.83 M Semrush visits lastest month: 1.43 K

  • Host name: cluster006.ovh.net
  • IP address: 213.186.33.17
  • Location: France
  • Latitude: 48.8582
  • Longitude: 2.3387
  • Timezone: Europe/Paris

Loading ...

More informations about "Ciloa"

Ciloa, Inspired by exosomes

Ciloa is dedicated to the development of new high potential therapies. It was built on more than 15 years of research on bio-drug development technology using exosomes. Ciloa’s technology …See details»

EXPERIENCED MANAGEMENT TEAM - ciloa.fr

Robert founded Ciloa and was its CEO during 4 years. Expertise : viral RNA and proteins, virus isolation, epidemiology, phylogenesis, poly- & monoclonal antibodies, epitope mapping, 3D-modeling of proteins, diagnostics.See details»

Application fields - Ciloa

Ciloa's technology address several therapeutic areas through its three main applications : antibodies, vaccines, and therapeutic vectors. The antibodies and therapeutic vectors based …See details»

Ciloa | BIO-Europe Spring - Informa Connect

Ciloa is a French preclinical biotechnology company, spin-off from the CNRS and the University of Montpellier, with the world's leading experience in the development of exosome-based …See details»

Ciloa - Crunchbase Company Profile & Funding

View contacts for Ciloa to access new leads and connect with decision-makers. Ciloa technology is the only one allowing to produce all types of membrane proteins with their native conformation on exosomes. It allows to load …See details»

Ciloa SAS - LinkedIn

CILOA’S CUSTOMIZED EXOSOMES FOR INNOVATIVE THERAPEUTICS Ciloa is the most experienced exosome-based R&D Company dedicated to the development of new high …See details»

Ciloa - Eurobiomed

Ciloa agit sur la machinerie cellulaire impliquée dans la production d’exosomes et personnalise in vivo ces exosomes pour qu’ils contiennent i) des complexes protéiques membranaires natifs …See details»

Ciloa secures €5 million for the development of its new …

Montpellier, France, March 08th 2022 – Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that it has secured €5 million to pursue its development programs for exosome-based biomedicines and …See details»

A BREAKTHROUGH EXOSOME TECHNOLOGY - Ciloa

Ciloa’s technology makes possible to have a cell producing a perfect antigen for an optimal immune response. We act directly on the cellular machinery to naturally produce membrane …See details»

Bio-Sourcing, Ciloa and Intract Pharma launch €3.4M …

May 28, 2024 · Ciloa is a French preclinical stage biotechnology company and pioneer in the field of extracellular vesicle bioengineering (EV). The company aims to create new generations of EV-based biotherapies and vaccines.See details»

Biotech, vaccins : Ciloa (Montpellier), une nouvelle unité de ...

Dec 8, 2020 · Dans le cadre du développement d’une nouvelle génération de vaccins et vecteurs thérapeutiques basée sur les exosomes, la biotech française Ciloa crée sa nouvelle unité de …See details»

Ciloa Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Ciloa. Use the PitchBook Platform to explore the full profile.See details»

Ciloa, les traitements thérapeutiques à base d’exosomes

Basée à Montpellier, la société développe une nouvelle génération de traitements fondés sur les exosomes, vésicules nanoscopiques qui transmettent des informations aux cellules du corps …See details»

Working with us - Ciloa

Ciloa is uniquely positioned to support your projects aiming to create new therapeutic and new preventive solutions. Our recombinant exosomes offer : Get unique answer to your needs with …See details»

Ciloa Secures €5 Million for the Development of Its New …

Mar 8, 2022 · MONTPELLIER, France-- ( BUSINESS WIRE )-- Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that it has secured €5 million to …See details»

Montpellier : un aperçu de la médecine du futur à Ciloa, société ...

Feb 15, 2022 · La ministre de l’Enseignement supérieur, de la Recherche et de l’Innovation a en effet visité la société Ciloa, située au nord de la ville.See details»

Ciloa secures €5 million for biomedicines and vaccines development

Montpellier, France, March 08th 2022 – Ciloa, a pioneer company expert in the in vivo customization of exosomes, announced today that it has secured €5 million to pursue its …See details»

Ciloa veut utiliser les exosomes pour traiter des virus majeurs

Mar 7, 2022 · Société pionnière dans la personnalisation in vivo d'exosomes, qui sont de minuscules vésicules extracellulaires naturelles, Ciloa annonce ce lundi avoir réuni 5 millions …See details»

Contact - Ciloa

356 rue Maurice Bejart, Montpellier 34080, France. +33 (0) 499 745 987. [email protected]. CONTACT US. For information about the company, press relation, business development or …See details»

linkstock.net © 2022. All rights reserved